Dr. Durie is the Director of Myeloma Research for AMyC Consortium. Along with Dr. Sydney Salmon, Dr. Durie co-created the Durie/Salmon Staging System, which is used worldwide for evaluating patients with myeloma.
Dr. Durie is an attending physician at the Cedars-Sinai Medical Center, with offices located in the Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute. Previously, he was a professor at the University of Arizona, College of Medicine, and the Charing Cross and Westminster School of Medicine at the University of London.
Dr. Durie founded and now chairs the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is chair of the IMF's International Myeloma Working Group, a consortium of 160 myeloma experts from around the world.
Dr. Durie has written over 400 research papers, sixteen book chapters, and five books. Dr. Durie is also an international patent holder for scintillation autoradiography.
He is the recipient of numerous honors and awards for excellence. He's a Leukemia Society of America Scholar and a U.S. Hematologic Research Foundation Annual Awardee. Dr. Durie received the 2006 Robert A. Kyle Lifetime Achievement Award, which honors a physician who most exemplifies singular dedication to and compassion for myeloma patients in the search for the best treatment for myeloma. In addition, in 2009, Dr. Durie also received the prestigious Waldenström’s Award in recognition of his many contributions to the field of multiple myeloma.
Dr. Durie is a Marquis member of "Who's Who in America" and "The Best Doctors in America."
Dr. Durie received his medical degree from the University of Edinburgh Medical School, Scotland in 1966. He completed his residencies and fellowships at the Mayo Clinic and the University of Minnesota. Dr. Durie is board certified by the American Board of Internal Medicine with subspecialties in both medical oncology and hematology.